| pubmed-article:21172456 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21172456 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
| pubmed-article:21172456 | lifeskim:mentions | umls-concept:C0005516 | lld:lifeskim |
| pubmed-article:21172456 | lifeskim:mentions | umls-concept:C1538160 | lld:lifeskim |
| pubmed-article:21172456 | lifeskim:mentions | umls-concept:C1417166 | lld:lifeskim |
| pubmed-article:21172456 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
| pubmed-article:21172456 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
| pubmed-article:21172456 | pubmed:issue | 3-4 | lld:pubmed |
| pubmed-article:21172456 | pubmed:dateCreated | 2011-3-28 | lld:pubmed |
| pubmed-article:21172456 | pubmed:abstractText | Sizn1 (Zcchc12) is a transcriptional co-activator that positively modulates bone morphogenic protein (BMP) signaling through its interaction with Smad family members and CBP. We have demonstrated a role for Sizn1 in basal forebrain cholinergic neuron specific gene expression. Furthermore, mutations in SIZN1 have been associated with X-linked mental retardation. Given the defined role of SIZN1 in mental retardation, knowing its complete forebrain expression pattern is essential to further elucidating its role in cognition. To better define the dynamic expression pattern of Sizn1 during forebrain development, we investigated its expression in mouse brain development from embryonic day 8.0 (E8.0) to adult. We found that Sizn1 is primarily restricted to the ventral forebrain including the medial ganglionic eminence, the septum, amygdala, and striatum. In addition, Sizn1 expression is detected in the cortical hem and pallial-subpallial boundary (PSB; anti-hem); both sources of Cajal-Retzius cells. Sizn1 expression in the dorsal forebrain is restricted to a subset of cells in the marginal zone that also express Reln, indicative of Cajal-Retzius cells. These data provide novel information on brain regions and cell types that express Sizn1, facilitating further investigations into the function of Sizn1 in both development and the pathogenesis of mental retardation. | lld:pubmed |
| pubmed-article:21172456 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21172456 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21172456 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21172456 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21172456 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21172456 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21172456 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21172456 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21172456 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21172456 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21172456 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21172456 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21172456 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21172456 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21172456 | pubmed:issn | 1872-7298 | lld:pubmed |
| pubmed-article:21172456 | pubmed:author | pubmed-author:GoldenJeffrey... | lld:pubmed |
| pubmed-article:21172456 | pubmed:author | pubmed-author:LimYoungshinY | lld:pubmed |
| pubmed-article:21172456 | pubmed:author | pubmed-author:ChoGinamG | lld:pubmed |
| pubmed-article:21172456 | pubmed:copyrightInfo | Copyright © 2010 Elsevier B.V. All rights reserved. | lld:pubmed |
| pubmed-article:21172456 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21172456 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:21172456 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21172456 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21172456 | pubmed:pagination | 216-20 | lld:pubmed |
| pubmed-article:21172456 | pubmed:meshHeading | pubmed-meshheading:21172456... | lld:pubmed |
| pubmed-article:21172456 | pubmed:meshHeading | pubmed-meshheading:21172456... | lld:pubmed |
| pubmed-article:21172456 | pubmed:meshHeading | pubmed-meshheading:21172456... | lld:pubmed |
| pubmed-article:21172456 | pubmed:meshHeading | pubmed-meshheading:21172456... | lld:pubmed |
| pubmed-article:21172456 | pubmed:meshHeading | pubmed-meshheading:21172456... | lld:pubmed |
| pubmed-article:21172456 | pubmed:meshHeading | pubmed-meshheading:21172456... | lld:pubmed |
| pubmed-article:21172456 | pubmed:meshHeading | pubmed-meshheading:21172456... | lld:pubmed |
| pubmed-article:21172456 | pubmed:meshHeading | pubmed-meshheading:21172456... | lld:pubmed |
| pubmed-article:21172456 | pubmed:meshHeading | pubmed-meshheading:21172456... | lld:pubmed |
| pubmed-article:21172456 | pubmed:meshHeading | pubmed-meshheading:21172456... | lld:pubmed |
| pubmed-article:21172456 | pubmed:meshHeading | pubmed-meshheading:21172456... | lld:pubmed |
| pubmed-article:21172456 | pubmed:meshHeading | pubmed-meshheading:21172456... | lld:pubmed |
| pubmed-article:21172456 | pubmed:meshHeading | pubmed-meshheading:21172456... | lld:pubmed |
| pubmed-article:21172456 | pubmed:meshHeading | pubmed-meshheading:21172456... | lld:pubmed |
| pubmed-article:21172456 | pubmed:meshHeading | pubmed-meshheading:21172456... | lld:pubmed |
| pubmed-article:21172456 | pubmed:meshHeading | pubmed-meshheading:21172456... | lld:pubmed |
| pubmed-article:21172456 | pubmed:meshHeading | pubmed-meshheading:21172456... | lld:pubmed |
| pubmed-article:21172456 | pubmed:meshHeading | pubmed-meshheading:21172456... | lld:pubmed |
| pubmed-article:21172456 | pubmed:meshHeading | pubmed-meshheading:21172456... | lld:pubmed |
| pubmed-article:21172456 | pubmed:meshHeading | pubmed-meshheading:21172456... | lld:pubmed |
| pubmed-article:21172456 | pubmed:meshHeading | pubmed-meshheading:21172456... | lld:pubmed |
| pubmed-article:21172456 | pubmed:meshHeading | pubmed-meshheading:21172456... | lld:pubmed |
| pubmed-article:21172456 | pubmed:articleTitle | XLMR candidate mouse gene, Zcchc12 (Sizn1) is a novel marker of Cajal-Retzius cells. | lld:pubmed |
| pubmed-article:21172456 | pubmed:affiliation | Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. | lld:pubmed |
| pubmed-article:21172456 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21172456 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| entrez-gene:14580 | entrezgene:pubmed | pubmed-article:21172456 | lld:entrezgene |
| entrez-gene:19699 | entrezgene:pubmed | pubmed-article:21172456 | lld:entrezgene |
| entrez-gene:20423 | entrezgene:pubmed | pubmed-article:21172456 | lld:entrezgene |
| entrez-gene:52897 | entrezgene:pubmed | pubmed-article:21172456 | lld:entrezgene |
| entrez-gene:72693 | entrezgene:pubmed | pubmed-article:21172456 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:21172456 | lld:entrezgene |
